JORDAN HARRINGTON: Open Payments
NPI 1548600612 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 49 payments from 14 companies in 2025. Trend: 2023 $670 · 2024 $658 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 19 | $339 |
| Novartis Pharmaceuticals Corporation | 7 | $139 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Edwards Lifesciences Corporation | 2 | $50 |
| SCPHARMACEUTICALS INC. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| ABIOMED | 1 | $18 |
Products named: CONFIRM RX, LEQVIO, LifeVest, GALLANT, JARDIANCE, FUROSCIX, ASSURITY, Kerendia.
Industry payments across MS — which companies pay providers there.
